Download software Tutorial videos
Subscription & data-feed pricing Class schedule


New account application Trading resources
Margin rates Stock & option commissions

Attention: Discussion forums are read-only for extended maintenance until further notice.
Welcome Guest, please sign in to participate in a discussion. Search | Active Topics |

Profile: LQR63300
About
User Name: LQR63300
Groups: Gold User, Member, Platinum User, TeleChart
Rank: Registered User
Real Name:
Location
Occupation:
Interests:
Gender: Unsure
Statistics
Joined: Friday, February 24, 2006
Last Visit: Monday, August 3, 2009 9:54:58 AM
Number of Posts: 2
[0.00% of all post / 0.00 posts per day]
Avatar
Last 10 Posts
Topic: Diceman... what stock you can recommend?
Posted: Sunday, April 15, 2007 10:41:41 AM
I would recommend,XOMA, for both short term and long term. I have been following XOMA for more than two years, since DNA recieved the FDA clearance for Raptiva, and since then the clearance for Lucentis which appears to be a 1 billion dollar antibody. XOMA collects royalties on these two drugs and since the success of their technology has been proven more than once, they have established major relationships with other big pharma to continue on. I think this stock is extremely under valued specially since they have collected more than 10million in rolyalties for the DNA drugs, and already an additional 10 million to be added to next quarters revenue. This I see a very good short term play and long term play if that is your cup of TEA.
Topic: Your opinion on ORCH
Posted: Wednesday, April 11, 2007 6:27:52 PM
I think the chart is looking very nice. ORCH went under my radar for quite some time. Your opinion is appreciated.